In vitro assays for the functional characterization of (psychedelic) substances at the serotonin receptor 5-HT2AR
- Author
- Eline Pottie and Christophe Stove (UGent)
- Organization
- Abstract
- Serotonergic psychedelics are substances that induce alterations in mood, perception, and thought, and have the activation of serotonin (5-HT) 2A receptors (5-HT(2A)Rs) as a main pharmacological mechanism. Besides their appearance on the (illicit) drug market, e.g. as new psychoactive substances, their potential therapeutic application is increasingly explored. This group of substances demonstrates a broad structural variety, leading to insufficiently described structure-activity relationships, hence illustrating the need for better functional characterization. This review therefore elaborates on the in vitro molecular techniques that have been used the most abundantly for the characterization of (psychedelic) 5-HT2AR agonists. More specifically, this review covers assays to monitor the canonical G protein signaling pathway (e.g. measuring G protein recruitment/activation, inositol phosphate accumulation, or Ca2+ mobilization), assays to monitor non-canonical G protein signaling (such as arachidonic acid release), assays to monitor beta-arrestin recruitment or signaling, and assays to monitor receptor conformational changes. In particular, focus lies on the mechanism behind the techniques, and the specific advantages and challenges that are associated with these. Additionally, several variables are discussed that one should consider when attempting to compare functional outcomes from different studies, both linked to the specific assay mechanism and linked to its specific execution, as these may heavily impact the assay outcome.
- Keywords
- 5-HT2AR, GPCR, hallucinogens, in vitro assay, psychedelics, serotonin, 5-HYDROXYTRYPTAMINE TYPE 2A, AGONIST-DIRECTED TRAFFICKING, G-PROTEIN, PHOSPHOLIPASE-C, PHARMACOLOGICAL CHARACTERIZATION, TERNARY COMPLEX, HALLUCINOGENIC PHENETHYLAMINE, INTERNATIONAL UNION, SIGNALING PATHWAYS, INTRINSIC ACTIVITY
Downloads
-
Pottie post J Neurochem 012022.docx
- full text (Accepted manuscript)
- |
- open access
- |
- ZIP archive
- |
- 521.29 KB
-
(...).pdf
- full text (Published version)
- |
- UGent only
- |
- |
- 1.74 MB
Citation
Please use this url to cite or link to this publication: http://hdl.handle.net/1854/LU-8751265
- MLA
- Pottie, Eline, and Christophe Stove. “In Vitro Assays for the Functional Characterization of (Psychedelic) Substances at the Serotonin Receptor 5-HT2AR.” JOURNAL OF NEUROCHEMISTRY, vol. 162, no. 1, 2022, pp. 39–59, doi:10.1111/jnc.15570.
- APA
- Pottie, E., & Stove, C. (2022). In vitro assays for the functional characterization of (psychedelic) substances at the serotonin receptor 5-HT2AR. JOURNAL OF NEUROCHEMISTRY, 162(1), 39–59. https://doi.org/10.1111/jnc.15570
- Chicago author-date
- Pottie, Eline, and Christophe Stove. 2022. “In Vitro Assays for the Functional Characterization of (Psychedelic) Substances at the Serotonin Receptor 5-HT2AR.” JOURNAL OF NEUROCHEMISTRY 162 (1): 39–59. https://doi.org/10.1111/jnc.15570.
- Chicago author-date (all authors)
- Pottie, Eline, and Christophe Stove. 2022. “In Vitro Assays for the Functional Characterization of (Psychedelic) Substances at the Serotonin Receptor 5-HT2AR.” JOURNAL OF NEUROCHEMISTRY 162 (1): 39–59. doi:10.1111/jnc.15570.
- Vancouver
- 1.Pottie E, Stove C. In vitro assays for the functional characterization of (psychedelic) substances at the serotonin receptor 5-HT2AR. JOURNAL OF NEUROCHEMISTRY. 2022;162(1):39–59.
- IEEE
- [1]E. Pottie and C. Stove, “In vitro assays for the functional characterization of (psychedelic) substances at the serotonin receptor 5-HT2AR,” JOURNAL OF NEUROCHEMISTRY, vol. 162, no. 1, pp. 39–59, 2022.
@article{8751265,
abstract = {{Serotonergic psychedelics are substances that induce alterations in mood, perception, and thought, and have the activation of serotonin (5-HT) 2A receptors (5-HT(2A)Rs) as a main pharmacological mechanism. Besides their appearance on the (illicit) drug market, e.g. as new psychoactive substances, their potential therapeutic application is increasingly explored. This group of substances demonstrates a broad structural variety, leading to insufficiently described structure-activity relationships, hence illustrating the need for better functional characterization. This review therefore elaborates on the in vitro molecular techniques that have been used the most abundantly for the characterization of (psychedelic) 5-HT2AR agonists. More specifically, this review covers assays to monitor the canonical G protein signaling pathway (e.g. measuring G protein recruitment/activation, inositol phosphate accumulation, or Ca2+ mobilization), assays to monitor non-canonical G protein signaling (such as arachidonic acid release), assays to monitor beta-arrestin recruitment or signaling, and assays to monitor receptor conformational changes. In particular, focus lies on the mechanism behind the techniques, and the specific advantages and challenges that are associated with these. Additionally, several variables are discussed that one should consider when attempting to compare functional outcomes from different studies, both linked to the specific assay mechanism and linked to its specific execution, as these may heavily impact the assay outcome.}},
author = {{Pottie, Eline and Stove, Christophe}},
issn = {{0022-3042}},
journal = {{JOURNAL OF NEUROCHEMISTRY}},
keywords = {{5-HT2AR,GPCR,hallucinogens,in vitro assay,psychedelics,serotonin,5-HYDROXYTRYPTAMINE TYPE 2A,AGONIST-DIRECTED TRAFFICKING,G-PROTEIN,PHOSPHOLIPASE-C,PHARMACOLOGICAL CHARACTERIZATION,TERNARY COMPLEX,HALLUCINOGENIC PHENETHYLAMINE,INTERNATIONAL UNION,SIGNALING PATHWAYS,INTRINSIC ACTIVITY}},
language = {{eng}},
number = {{1}},
pages = {{39--59}},
title = {{In vitro assays for the functional characterization of (psychedelic) substances at the serotonin receptor 5-HT2AR}},
url = {{http://doi.org/10.1111/jnc.15570}},
volume = {{162}},
year = {{2022}},
}
- Altmetric
- View in Altmetric
- Web of Science
- Times cited: